Featured News
FOR IMMEDIATE RELEASE Avet Pharma Announces Leadership Transition: CEO George Svokos to Retire;Dan Lukasiewicz Promoted to Chief Commercial Officer EAST BRUNSWICK, NJ – Avet Pharma (“Avet”) announced today that President [...]
EAST BRUNSWICK, N.J., November 4, 2024: Avet Pharmaceuticals Inc. (“Avet”), formerly known as Heritage Pharmaceuticals Inc., announced today that the Company has entered into a settlement agreement with the State [...]
EAST BRUNSWICK, N.J., June 12, 2024: Avet Pharmaceuticals Inc. (“Avet”), formerly known as Heritage Pharmaceuticals Inc., announced today that the Company has entered into a settlement agreement with a putative [...]
EAST BRUNSWICK, N.J., January 24, 2024: Avet Pharmaceuticals Inc. (“Avet”), formerly known as Heritage Pharmaceuticals Inc., announced today that the Company has entered into a settlement agreement with a putative [...]
East Brunswick, NJ—July 15, 2022 – Avet Pharmaceuticals Inc., a rapid growth specialty pharmaceutical company focused on the development and distribution of generic medicines in the U.S. market, announced today [...]
Company to Launch Immediately to Address Current Market Shortage East Brunswick, NJ—April 7, 2022 – Avet Pharmaceuticals Inc. announced today the U.S. launch of its Propofol Injectable Emulsion, USP 10 [...]
